IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$59.43 USD
+0.36 (0.61%)
Updated Nov 29, 2023 04:00 PM ET
After-Market: $59.39 -0.04 (-0.07%) 4:42 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/06/2024
Time: -- |
12/2023 | $-0.45 | 0.00% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.59 per share. This reflects a positive earnings surprise of 57.63%. Look out for ITCI's next earnings release expected on March 06, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for ITCI
Wall Street Analysts Believe Intra-Cellular (ITCI) Could Rally 41.19%: Here's is How to Trade
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services